Summary: Weight loss injections, particularly GLP-1 receptor agonists such as semaglutide and liraglutide, can cause dizziness as an uncommon side effect in up to 1 in 100 people
It's hard to know if any given vial of compounded semaglutide is safe
Pharmacy partners: N/A Brand-name only (Ozempic, Wegovy, Zepbound, Mounjaro)
Share it with friends, then discover more great TV commercials on iSpot Published August 18, 2025 Advertiser Wegovy Advertiser Profiles Products Wegovy Wegovy Injection Promotions Patients may pay as little as $0 with insurance and $499 per month for self pay Songs None have been identified for this spot Phone 1-833-4-WEGOVY Ad URL Mood Informational Actors - Add None have been identified for this spot
According to the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), factors that can increase the risk of NAFLD include: Overweight or obesity High cholesterol or triglycerides Insulin resistance or Type 2 diabetes Metabolic syndrome, which can include high blood pressure, high waist size, high triglycerides, low good cholesterol level, and high blood sugar Possibly genetics Possibly a diet high in the sweetener fructose Michael Chichak, MD, medical director at MEDvidi, explains how fatty liver is associated with Type 2 diabetes and obesity: Fatty liver disease is linked with diabetes and obesity due to insulin resistance, which is a prominent feature of NAFLD
Protocol adjustments for side effect management When side effects occur, systematic adjustment of your protocol often resolves issues while maintaining benefits
.webp)
